Introduction In October, 1957, the Medical Staff of the Royal Free Hospital reported in the British Medical Journal an outbreak of an illness amongst the hospital staff in 1955. Between 13 July of that year and 24 November, 292 members of the medical, nursing, auxiliary medical, ancillary, and administrative staff were affected by the illness and, of these, 255 patients were admitted to hospita...

This report addresses the extent to which there may be scope for preventive programmes Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), and, if so, what economic benefits accrue from implementation of such programmes. We consider case prevention programmes, whether is ME/CFS, and are health derived conclude that little primary given ME/CFS attributable a combination host environment...

For the growing number of patients suffering from post-COVID-19 syndrome, there is little definitive guidance for treatment protocols or prognosis. Neurologic manifestations following acute COVID-19 infection are continually surfacing in literature, with fatigue being most common persistent symptom. This case study follows a 44-year-old female experiencing debilitating and neurologic symptoms p...

C fatigue syndrome (named by some as myalgic encephalomyelitis/chronic fatigue syndrome [ME/CFS]) frustrates many physicians. That is understandable because there are no diagnostic tests or proven treatments. Some physicians even insist that the illness has no biological basis. Patients who seek help from such physicians are unlikely to have a satisfying therapeutic experience. Fortunately, ME/...

Chronic Fatigue Syndrome (CFS) or Myalgic Encephalomyelitis (ME) is a debilitating disorder, affecting at least 250,000 people in the UK. Marked by debilitating fatigue, its aetiology is poorly understood and diagnosis controversial. A number of symptoms overlap with other illnesses with the result that CFS/ME is commonly misdiagnosed. It is important therefore that significant clinical feature...